JAY FAWVER: Open Payments
NPI 1164457404 · ANGOLA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305,986 in 285 payments from 7 companies in 2025. Trend: 2023 $317,190 · 2024 $254,354 · 2025 $305,986
Speaker / faculty: $151,930Honoraria: $90,344Travel & lodging: $42,061Consulting: $16,385Food & beverage: $5,266
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 99 | $116,657 |
| Axsome Therapeutics, Inc. | 70 | $112,832 |
| Alkermes, Inc. | 46 | $34,930 |
| Biogen, Inc. | 33 | $23,699 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $17,093 |
| Janssen Scientific Affairs, LLC | 10 | $651 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
Products named: SPRAVATO, Auvelity, LYBALVI, ZURZUVAE, CAPLYTA, REXULTI.
Industry payments across IN — which companies pay providers there.
